Guzman Alonso, Pilar Garrido, Judy S. Wang, Andrew G. Gianoukakis, Matthew H. Taylor, Stephen V. Liu, Luis G. Paz-Ares, Martin David Forster, David R. Spigel, Saad A. Khan, Jyoti D. Patel, Salman Rafi Punekar, Daniel Morgensztern, Susanne M. Arnold, Javier García-Corbacho, Matthew G. Krebs, Jack J. Welch, Sonia Serrano, Hendrik-Tobias Arkenau, Elena Garralda. "Final results of a phase 1 study of EP0031, a next generation selective RET inhibitor (SRI) in patients with SRI naïve or pretreated advanced RET-altered tumors.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8598